These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12852960)

  • 1. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.
    Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
    Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
    Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
    Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
    Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.
    Lewis DF; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP
    Toxicology; 1999 Nov; 139(1-2):53-79. PubMed ID: 10614688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
    Krusekopf S; Roots I; Hildebrandt AG; Kleeberg U
    Xenobiotica; 2003 Feb; 33(2):107-18. PubMed ID: 12623754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK; Chen J; Yeung EY
    Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities.
    Mikstacka R; Baer-Dubowska W; Wieczorek M; Sobiak S
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S77-83. PubMed ID: 18435436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
    Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
    Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
    Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
    Chang TK; Chen J; Benetton SA
    Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
    Yamaori S; Kushihara M; Yamamoto I; Watanabe K
    Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1B1 detection.
    Divi RL; Luch A; Verma M; Mahadevan B
    Curr Protoc Toxicol; 2012 Feb; Chapter 4():Unit 4.38. PubMed ID: 22511118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
    Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
    Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
    Chang SY; Chen C; Yang Z; Rodrigues AD
    Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.